These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9193014)

  • 1. Clinical predictors of transvenous defibrillation energy requirements.
    Khalighi K; Daly B; Leino EV; Shorofsky SR; Kavesh NG; Peters RW; Gold MR
    Am J Cardiol; 1997 Jan; 79(2):150-3. PubMed ID: 9193014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical predictors of transvenous biphasic defibrillation thresholds.
    Gold MR; Khalighi K; Kavesh NG; Daly B; Peters RW; Shorofsky SR
    Am J Cardiol; 1997 Jun; 79(12):1623-7. PubMed ID: 9202352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of defibrillation energy requirements with nonepicardial lead systems.
    Kopp DE; Blakeman BP; Kall JG; Olshansky B; Kinder CA; Wilber DJ
    Pacing Clin Electrophysiol; 1995 Feb; 18(2):253-60. PubMed ID: 7731873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system.
    Rashba EJ; Shorofsky SR; Brown T; Peters RW; Gold MR
    Heart Rhythm; 2005 Jan; 2(1):49-54. PubMed ID: 15851265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Swiatecka G
    Kardiol Pol; 2005 Apr; 62(4):317-28; discussion 329-31. PubMed ID: 15928737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment.
    Kühlkamp V; Mewis C; Suchalla R; Mermi J; Dörnberger V; Seipel L
    Int J Cardiol; 1999 Jun; 69(3):271-9. PubMed ID: 10402110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
    Leong-Sit P; Gula LJ; Diamantouros P; Krahn AD; Skanes AC; Yee R; Klein GJ
    Am Heart J; 2006 Dec; 152(6):1104-8. PubMed ID: 17161062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized evaluation of a nonthoracotomy implantable cardioverter defibrillator lead system. Endotak/PRX Investigator Group.
    Baker JH; Epstein AE; Voshage-Stahl L
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):72-8. PubMed ID: 9121974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors of defibrillation energy requirements.
    Neuzner J; Bahawar H; Berkowitsch A; Michel U; Schlepper M; Pitschner HF
    Am J Cardiol; 1997 Jan; 79(2):205-6. PubMed ID: 9193027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
    Hohnloser SH; Dorian P; Roberts R; Gent M; Israel CW; Fain E; Champagne J; Connolly SJ
    Circulation; 2006 Jul; 114(2):104-9. PubMed ID: 16818810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors of the defibrillation threshold with the unipolar implantable defibrillation system.
    Raitt MH; Johnson G; Dolack GL; Poole JE; Kudenchuk PJ; Bardy GH
    J Am Coll Cardiol; 1995 Jun; 25(7):1576-83. PubMed ID: 7759708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of nonthoracotomy biphasic defibrillation.
    Horton RP; Canby RC; Román CA; Hull ML; Kaye SA; Jessen ME; Page RL
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):60-4. PubMed ID: 9121972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polarity reversal improves defibrillation efficacy in patients undergoing transvenous cardioverter defibrillator implantation with biphasic shocks.
    Schauerte P; Stellbrink C; Schöndube FA; Löser H; Haltern G; Messmer BJ; Hanrath P
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 1):301-6. PubMed ID: 9058867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of defibrillation thresholds with an active pectoral pulse generator lead system.
    Hodgson DM; Olsovsky MR; Shorofsky SR; Daly B; Gold MR
    Pacing Clin Electrophysiol; 2002 Apr; 25(4 Pt 1):408-13. PubMed ID: 11991364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantation of a unipolar cardioverter/defibrillator system under local anaesthesia.
    Stix G; Anvari A; Grabenwöger M; Merhaut C; Türel Z; Laufer G; Schmidinger H
    Eur Heart J; 1996 May; 17(5):764-8. PubMed ID: 8737108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of high defibrillation threshold in patients with implantable cardioverter-defibillator using a transvenous dual-coil lead.
    Mizukami K; Yokoshiki H; Mitsuyama H; Watanabe M; Tenma T; Matsui Y; Tsutsui H
    Circ J; 2015; 79(1):77-84. PubMed ID: 25391259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated defibrillation threshold when right-sided venous access is used for nonthoracotomy implantable defibrillator lead implantation. The Endotak Investigators.
    Epstein AE; Kay GN; Plumb VJ; Voshage-Stahl L; Hull ML
    J Cardiovasc Electrophysiol; 1995 Nov; 6(11):979-86. PubMed ID: 8589875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with elevated impedance with a nonthoracotomy defibrillation lead system.
    Kontos MC; Ellenbogen KA; Wood MA; Damiano RJ; Akosah KO; Nixon JV; Stambler BS
    Am J Cardiol; 1997 Jan; 79(1):48-52. PubMed ID: 9024735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transvenous biventricular defibrillation.
    Meisel E; Butter C; Philippon F; Higgins S; Strickberger SA; Smith J; Hahn S; Michel U; Schubert B; Pfeiffer D
    Am J Cardiol; 2000 Nov; 86(9A):76K-85K. PubMed ID: 11084104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.